Source comparison
Quickcomparison
Dose Range Imunofan 50–100 mcg Thymosin Alpha-1 1.6–3.2 mg Frequency Once daily Twice weekly Administration Subcutaneous injection Cycle Length 8-12 weeks Onset Speed Rapid (hours to days) Moderate (1-2 weeks) Evidence Level Limited human trials Moderate human
This comparison does not assign a generated winner or score.
- Dose Range
- Imunofan
- 50–100 mcg
- Thymosin Alpha-1
- 1.6–3.2 mg
- Frequency
- Once daily
- Twice weekly
- Administration
- Subcutaneous injection
- Cycle Length
- 8-12 weeks
- Onset Speed
- Rapid (hours to days)
- Moderate (1-2 weeks)
- Evidence Level
- Limited human trials
- Moderate human trials (Phase 1-2)
- Efficacy